Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
epratuzumab | b-cell receptor cd22 | biotech | Successful target | TTD , drugbank , DGIDB | Lymphoma[MeSHID:D008223] Lupus Erythematosus Systemic[MeSHID:D008180] leukemia[MeSHID:D007938] Lymph[MeSHID:D008196] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Graft Rejection[MeSHID:D006084] |
53.04 | investigational,phase 3 | unknown |
click here to return to the previous page |